Price
Target price
€36.26
€36.26
-1.890%
-0.7
-1.890%
€52.50
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Schott Pharma & Co. Kgaa
sharewise wants to provide you with the best news and tools for Schott Pharma & Co. Kgaa, so we directly link to the best financial data sources.
Financials
News
EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
EQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
EQS-News: SCHOTT Pharma reports good start into fiscal year 2024
EQS-News: SCHOTT Pharma reports good start into fiscal year 2024
EQS-News: SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory
EQS-News: SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory
EQS-News: SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance
EQS-News: SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance
EQS-News: Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company
EQS-News: Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company